MENOPUR: payments to doctors
Payments that named MENOPUR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.6M
- Providers
- 2,482
- Transactions
- 23,870
- Average per transaction
- $109
The per-transaction average — $109 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,482 providers the average total is $1,053, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Ferring Pharmaceuticals Inc. | $2,518,240 | 96.4% |
| Ferring Pharmaceuticals Private Ltd | $34,356 | 1.3% |
| Ferring Pharmaceuticals Pty Ltd | $25,547 | 1.0% |
| Ferring International Center SA | $16,830 | 0.6% |
| Ferring Inc. | $13,227 | 0.5% |
| Ferring Sendirian Berhad | $4,279 | 0.2% |
| Ferring International Pharmascience Center US | $704 | 0.0% |
| Ferring Pharmaceuticals SA Rep Office Middle East | $314 | 0.0% |